Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus

Lupus

Volumn 7, Issue 7, 1998, Pages 455-461

  Papo, T ^a   Parizot, C ^a   Ortova, M ^a   Piette, J C ^a   Frances, C ^a   Debre, P ^a   Godeau, P ^a   Gorochov, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CD 95; Lupus; Nephritis; T lymphocyte

Indexed keywords

FAS ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ALTERNATIVE SPLICING; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031694948     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920460     Document Type: Article

References (39)

1. Fraser A, Evan G. A license to kill. Cell 1996; 85 : 781-784.
2. Cheng J et al Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263 : 1759-1762.
3. Chornezynski P, Sacchi N Single-step method of RNA isolation by acid guamdinium thiocyanate-phenol-chloroform extraction Ann Biochem 1987; 162 : 156-159.
4. Itoh N et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66 : 233-243.
5. Pannetier C, Even J, Kourilsky P T-cell repertoire diversity and clonal expansions in normal and clinical samples Immunol Today 1995; 16 : 176-181.
6. Gonzalez EN. Rothfield NF Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus. N Engl J Med 1966; 274: 1333-1338.
7. Aarden CA, de Groot ER, Fedkamp TEW. Crithidiae lucihae, a simple substrate for the determination of anti ds-DNA with immunofluorescence technique. Ann NY Acad Sci 1975; 254 : 505-515.
8. Schur PH, Deangelis D, Jackson JM Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. Clin Exp Immunol 1974; 17 : 209-218.
9. Piqueras B, Autran B, Debré P, Gorochov G. Detection of apoptosis at the single cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks Biotechniques 1996; 20 : 634-640.
10. Tan EM et al The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25 : 1271-1277.
11. Bombardier C et al Derivation of the SLEDAI A disease activity index for lupus patients. Arthritis Rheum 1992; 35 : 630-639.
12. Arase H, Arase N, Saito K Fas-mediated cytotoxicity by freshly isolated natural killer cells J Exp Med 1995; 181 : 1235-1238.
13. Dhem J et al Autocrine T-cell suicide by APO-1/(Fas/CD95). Nature 1995; 373 : 438-441.
14. Ju ST et al Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373 : 444-448.
15. Nagata S, Suda T. Fas and Fas ligand: Ipr and gld mutations. Immunol Today 1995; 16 : 39-43.
16. Ito RM et al. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum 1997; 40: 1054-1063.
17. Fisher GH et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81 : 935-946.
18. Rieux-Laucat F et al Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268 : 1347-1349.
19. Le Deist F et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions Lancet 1996; 348 : 719-723.
20. Drappa J et al. Fas gene mutations in the Canale-Srmth syndrome an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335: 1643-1649.
21. Sneller MC et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997; 89: 1341-1348.
22. Mysler E et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93: 1029-1034.
23. McNally J et al. Fas ligand expression and function in systemic lupus erythematosus. J Immunol 1997; 159: 4628-4636.
24. Wu J et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98: 1107-1113.
25. Goel N et al. Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease. Arthritic Rheum 1995; 38: 1738-1743.
26. Knipping E et al. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38: 1735-1737.
27. Jodo S et al. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases Clin Exp Immunol 1997; 107 : 89-95
28. Nozawa K et al. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 1997; 40: 1126-1129.
29. Wolf RE, Brelsford WG Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31 : 729-735.
30. Savill J, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis Immunol Today 1993; 14 : 131-136.
31. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus J Immunol 1994; 152 : 3685-3692.
32. Lorenz HM et al In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40 : 306-317.
33. Van Houten N, Budd RC. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol 1992; 149: 2513-2517.
34. Yoshino T et al. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994; 83: 1856-1861.
35. Sato T, Ine S, Kitada S, Reed JC. FAP-1: a protein tyro-sine phosphatase that associates with Fas Science 1995; 268 : 411-415.
36. Golstein P. Controlling cell death Science 1997; 275 : 1081-1082.
37. Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100: 2622-2633.
38. Rathmell JC et al. CD95 (Fas)-dependant elimination of self-reactive B cells upon interaction with CD4 T cells. Nature 1995; 376 : 181-184.
39. Richardson BC et al Monocyte apoptosis in patients with active lupus. Arthritis Rheum 1996; 39 : 1432-1434.